赛佳明,马学晓,邱晨生,陈伯华,胡有谷.慢病毒载体GV115介导Caspase-3 siRNA转染人椎间盘髓核细胞的生物学效应[J].中国脊柱脊髓杂志,2015,(12):1090-1094.
慢病毒载体GV115介导Caspase-3 siRNA转染人椎间盘髓核细胞的生物学效应
中文关键词:  髓核细胞  慢病毒  Caspase-3  RNA干扰  基因治疗
中文摘要:
  【摘要】 目的:研究慢病毒载体GV115介导Caspase-3 siRNA转染人椎间盘髓核细胞的生物学效应。方法:采集12例外伤致脊柱爆裂性骨折患者(22~36岁)术中切除的椎间盘髓核组织,采用组织块法分离培养髓核细胞并传代。取第2代髓核细胞,分为GV115-Caspase3 siRNA组、GV115组和对照组,各组12个细胞培养孔。在荧光显微镜下观察计数阳性髓核细胞,计算GV115-Caspase3 siRNA对人椎间盘髓核细胞的转染效率;采用免疫荧光法检测三组髓核细胞中Caspase-3表达;采用MTT法检测三组髓核细胞活性;采用Western-Blot法和Antonopulos法分别检测三组髓核细胞的Ⅱ型胶原和蛋白多糖含量。结果:椎间盘髓核细胞被成功分离培养,培养1周后细胞达到80%融合,进行传代培养。转染后1周(85.6±1.3)%的髓核细胞可被GV115-Caspase3 siRNA转染而表达绿色荧光素。GV115-Caspase3 siRNA组Caspase-3免疫荧光阳性细胞率[(19.4±3.2)%]较GV115组[(84.3±9.2)%]和对照组[(83.9±8.7)%]明显减少(P<0.05),OD值(1.56±0.21)较GV115组(0.91±0.15)和对照组(0.92±0.17)高(P<0.05),Ⅱ型胶原免疫印迹染色强度(1.32±0.09)较GV115组(0.81±0.05)和对照组(0.79±0.04)高(P<0.05),蛋白多糖含量(0.56±0.09) 较GV115组(0.35±0.06)和对照组(0.34±0.05)高(P<0.05)。结论:GV115-Caspase3 siRNA可高效转染人椎间盘髓核细胞,增强髓核细胞的生物活性,并促进细胞外基质的合成。
Biological effects of GV115-Caspase3 siRNA on human intervertebral disc nucleus pulpous cells
英文关键词:Nucleus pulposus cell  Lentivirus  Caspase-3  RNAi  Gene therapy
英文摘要:
  【Abstract】 Objectives: To explore the biological effects of GV115-Caspase3 siRNA on human intervertebral disc nucleus pulposus(hIDNP) cells. Methods: The hIDNP cells were collected from 12 patients with traumatic vertebral burst fracture(22-36 years old). The hIDNP cells were isolated and subcultured by using tissue culture technique. The cells of second generation were grouped into GV115-Caspase3 siRNA group, GV115 group and control group. The hIDNP cells were transfected by GV115-Caspase3 siRNA and detected by the immunofluence method. The viability of hIDNP cells was detected by MTT method. The synthesis of collagen type Ⅱ and glycosaminoglycan were detected by Western-Blot and Antonopulos methods. Results: The hIDNP cells were successfully isolated and cultured. After one week, the hIDNP cells reached 80% confluence, which were subcultured and transfected by GV115-Caspase3 siRNA, and the percentage of positive cells was (85.6±1.3)% under a fluorescence microscope. The Caspase-3 expression in GV115-Caspase3 siRNA group[(19.4±3.2)%] was less than that in the GV115 group[(84.3±9.2)%] or the control group[(83.9±8.7)%], the difference was statistically significant(P<0.05). The OD value of GV115-Caspase3 siRNA group(1.56±0.21) was higher than that of GV115 group(0.91±0.15) or control group(0.92±0.17), the difference was statistically significant(P<0.05). The collagen type Ⅱ immunoblotting staining intensity of GV115-Caspase3 siRNA group(1.32±0.09) was higher than that of GV115 group(0.81±0.05) or control group(0.79±0.04). The glycosaminoglycan content of GV115-Caspase3 siRNA group(0.56±0.09) was higher than that of GV115 group(0.35±0.06) or control group(0.34±0.05), the difference was statistically significant. Conclusions: GV115-Caspase3 siRNA can efficiently transfect the hIDNP cells, enhance the cells′ viability and promote the synthesis of extracellular matrix.
投稿时间:2015-10-13  修订日期:2015-11-17
DOI:
基金项目:国家自然科学基金资助项目(编号:81171758)
作者单位
赛佳明 青岛大学附属医院脊柱外科 266003 山东省青岛市 
马学晓 青岛大学附属医院脊柱外科 266003 山东省青岛市 
邱晨生 青岛大学附属医院脊柱外科 266003 山东省青岛市 
陈伯华  
胡有谷  
摘要点击次数: 1917
全文下载次数: 1843
查看全文  查看/发表评论  下载PDF阅读器
关闭